Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study

Tze‐Fan Chao; Yi‐Hsin Chan; Ta‐Chuan Tuan; Jo‐Nan Liao; Tzeng‐Ji Chen; Professor Gregory Lip; Shih‐Ann Chen

doi:10.1093/ehjqcco/qcab050

Shared by

Professor Gregory Lip

University of Liverpool

Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study

Article 2021 en

Authors

TC
Tze‐Fan Chao
YC
Yi‐Hsin Chan
TT
Ta‐Chuan Tuan

Abstract

1 min read

For AF patients with an intermediate risk of stroke (i.e. a single non-sex stroke risk factor) but at high bleeding risk, the use of OACs was still significantly associated with a better overall clinical outcome.

Discussion(0)

No comments yet. Be the first to comment.

Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study

Abstract

Discussion(0)

Related publications

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

Oral anticoagulants in extremely high risk very elderly (&gt;90 years) patients with Atrial Fibrillation

Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation　― A Nationwide Cohort Study ―

Continuation or discontinuation of oral anticoagulants after an increase in HAS-BLED scores and the risks of clinical outcomes in patients with atrial fibrillation. a nationwide cohort study

Related publications

Article2021
Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk
Article2021

Article2021
Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk
Article2021

Article2020
Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation
Article2020

Article2019
Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation　― A Nationwide Cohort Study ―
Article2019

Article2020
Continuation or discontinuation of oral anticoagulants after an increase in HAS-BLED scores and the risks of clinical outcomes in patients with atrial fibrillation. a nationwide cohort study
Article2020

Should oral anticoagulants still be prescribed to patients with atrial fibrillation with a single stroke risk factor but at high bleeding risk? A nationwide cohort study

Abstract

Discussion(0)

Related publications

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

Oral anticoagulants in extremely high risk very elderly (&amp;gt;90 years) patients with Atrial Fibrillation

Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation ― A Nationwide Cohort Study ―

Continuation or discontinuation of oral anticoagulants after an increase in HAS-BLED scores and the risks of clinical outcomes in patients with atrial fibrillation. a nationwide cohort study

Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation

Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation　― A Nationwide Cohort Study ―